CURRICULUM VITAE
Personal
Last Name: Cosme Díaz
Name: Karelia
Nationality: Cuban
Address: Ave: 31 No. 18207 e/ 182 y 184 Playa. Havana City
Professional address: Ave. 31 e/158 y 190, 10600, Playa
Telephone: 271 81 64
Educational:
Havana University
(1969-1975) Faculty of Veterinarian
Speciality: Epizootiology
Scientific Category: Auxiliary.
Grade: Doctor in Science Veterinaria
Technologist of Prime Level
Post-grade Courses:
1. Ambient cleaning. Cuba. Julio, 1980.
2. Veterinaries Frontier Services. Epizootiology. Cuba. July,
1980.
3. Geodesy and Cartography. December 1981.
4. International Sanitary Control. Cuba. January 1983.
5. General and Especial Course of Epizootiology. INMV. April,
1983.
6. Transmissible diseases of fauna. Cuba. Nov. 1985.
7. Modern Diagnostic Techniques. FIOCRUZ. Brazil. PNUD. Feb.-March
1988.
8. Molecular Biology. 1989.
9. Seminary of resulted annex 4. Scientific Council of CIGB April
1990
10. Taller Primer Iberoamerican of Gnotobiology. ICLAS. CENPALAB.
Nov. 1990.
11. Centro American and Caribbean Course of "Biomodels in
Experimentation". Costa Rica. ICLAS. Feb. 1992.
12. International Course of Use and Care of Gnotobiótic
Animal. 1992
13. Good Manufacturing Practice. December CIGB 1992-January1993.
14. Seminary of resulted Annex 4 Scientific Council of CIGB. July
1993
15. Laboratory Animal. Ethic, Legislation and regulations. CENPALAB
Cuba. 1994.
16. Biology of laboratory animals. CENPALAB Cuba. 1994.
17. Direction management of quality. CIGB, 1994.
18. Facility and Protected System for Animals de lab. CENPALAB.
Cuba. Dec 1994 January 1995.
19. Compared medicine, Biosafety and Zoonosys of laboratory animals.
CENPALAB. Cuba January to March,1995.
20. System of Laboratory Animal Production. CENPALAB, Cuba. March-April
1995.
21. Biomodels. CENPALAB. Cuba. April-May1995.
22. Economics Aspects for production and use of laboratory animals.
CENPALAB Cuba. May-June1995.
23. Nutrition of laboratory animals. CENPALAB. Cuba. June-July
1995.
24. Marketing to Services. National Center of higher studies of
Bank. Cuba. March 1996.
25. Basic course of Production. Cuba. April- July1996.
26. Second course of Animal Model. Costa Rica. 1997.
27. Project Integrated Direction. (DIP). High School of Basic
Industry. Cuba. April 1999.
28. Course for Auditors interns of the Quality Systems according
to ISO 9001-94. February 1999. Cuba. Lloyd s Register.
29. Module I: Introduction of Science for Laboratory Animals.
Costa Rica University 2000.
30. Module II: Laboratory Animal Biology. Costa Rica University
2000.
31. Taller Laboratory Animal nutrition. Costa Rica University
2000.
32. Course of "Biotherium" Costa Rica University 2000.
33. "Roll of high management in Norm ISO 9000" 25 de
October. 2001.
34. Computation course. February 2002.
Training in and out of the Country:
- Basic techniques of Immunology. FIOCRUZ. Brazil. 1988.
- Hollow Fiber Bioreactor. Butantan Institute. Brazil. 1990.
- Quality Control of bacterial and virals vaccine. INCQS. Brazil.
Oct. 1992.
- Training about Biological assays in Animals Models in polyvalent
vaccines. National Institute of Quality Control for Health (INCQS),
FIOCRUZ. Brazil. September 1995.
- Training in Maintenance and Care of Primates (Chimps). Centre
of Primate Research. Netherlands. 2000
PROFESIONAL EXPERIENC:
Academic.
- Parasitology professor. 1968- 1973.
- Assistant professor of Parasitology in clinical laboratory.
Havana University 1974.
- Principal professor of basic course "Production in vivo
and in vitro again Monoclonal antibodies. Oswald Cruz Foundation.
Brazil.1992
- Coordinator and principal professor of theory and practice training
the Technicians and professionals of CENPALAB, about tumoral Ascites
production in mice. CIGB 1993
- Principal professor to the course "Care and Use of Gnotobiotic
animals. Authonoma University. Barcelona, Spain. 1994
- Professor to the course "Application of biological assays
in Biotechnological Industry. CIGB 1998
- Principal professor to the course "Use of laboratory animal
in Biomedical Science. Animals Models. CIGB Camaguey 1998.
- Professor to the course "Updating of Regulations for quality
auditors. CIGB.1998.
- Coordinator and head for training the specialist of the Center
for Medicaments and Control (CECMED). Potency test of Hepatitis
B recombinant vaccine. CIGB 1999
- Coordinator and principal professor to the course "Guidelines
for Care and Use of Laboratory Animal" 2000
- Coordinator and principal professor to the course "Guidelines
for Care and Use of Laboratory Animal" 2002
CONFERENCS:
1. Roll of laboratory animal in Biomedical research. Cuba. Oct.1986.
2. Exotic diseases in different animal species in Cuba. Nov. 1986.
3. Immunization system in animal models for antiserums production.
Cuba. January 1987.
4. Detection techniques for polyclonal antibodies. Cuba. March
1987.
5. Care and Use of laboratory animal. Cuba. April 1987.
6. Basics aspects of Immunology. Cuba. June. 1987.
7. Adequate comfort for laboratory animal. Facilities. Cuba. Sept.
1987A
8. Characteristics massive of Culture for hybrid cells. Cuba.
January 1988
9. Cellular culture in Bioreactors. Cuba. February 1988.
10. Influence of glutamine in grows of hybrids cells. Cuba. April
1988.
11. Large-scale in vitro Hybridoma culture. Cuba. Sept. 1998
12. Clamidia trachomatis. Biology. February. Cuba. 1989.
13. Preparation and obtention of antigen for detection and control
of monoclonal antibodies again C. trachomatis. Cuba. April 1989.
14. Diminution or suppression bovine serum in hybrid cells culture.
Cuba. June. 1989.
15. Use of hollow fiber reactors. Manufacture facility in cell
production. Cuba. July. 1990.
16. Classification of virals diseases (EEC, FDA), in mice and
its influence pharmaceutical product quality. Cuba. Feb. 1991.
17. Commercial production of Monoclonal Antibodies. Cuba. Mayo.1991.
18. EEC directresses for Care and Use of laboratory animals. Cuba.
January.1992
19. Comparison of ascites production for Monoclonal antibodies
in Balb/c-derived
cross-bred mice. May. 1992.
20. Kinetic of Ectromelia virus (Mousepox), transmission and clinical.
Cuba. April. 1992.
21. Virus diseases of Group II and I. Characteristics. Cuba. March
1993
22. Animal Models selection for use in the research. Cuba. June.
1993
23. Scale and production of tumoral ascites. Cuba. IX Forum of
Science and technique. August 1994
24. Scale and production of CB-HEP.1 Mabs, in Balb/c-derived cross-bred
mice. II Meeting ICLAS. Cuba. June.1994
25. Principle of Biosafety. Establishment of rules and regulations.
Care of Animal and human health. CENPALAB. February 1995.
26. Biological risk level. Physics, chemical and biologics agents.
Cuba. June 1995.
27. Factors affect the experimentation results. Experimental description.
Evaluation, discussion and interpretation of experimental results.
Cuba. August, 1995.
28. Water. Importance for life (Laboratory Animals). Cuba. Oct.
1995
29. Strategy of GAVAC vaccine. Medellin University. Colombia.
1996
30. Strategy of GAVAC vaccine. Laverlam Empress. Cali. Colombia.
1996
31. Strategy of GAVAC vaccine. Agroavic Empres. Bogotá.
Colombia. 1996.
32. Conference about: "Inform of ACCMAL (Centro Americana,
Caribbean and Mexican Association for Laboratory Animals) Commission
and situation of Laboratory Animals Science in Cuba". II
Course of Biomodels. Costa Rica. 1997.
33. Conference: "Utilization of laboratory animals in immunization
systems". XVI Pan-American Congress of Veterinarian Science.
Santa Cruz, Bolivia. 1998
34. Conference "Employ of laboratory animals in control vaccine
for human and veterinarian use. GAVAC". XVII Pan-American
Congress of Veterinarian Science. Panama. Sept. 2000
Professorial experience:
1. Guidelines for Maintenance and Care of the laboratory animal.
CIGB. Sept.-Nov. 1992.
2. Guidelines for Maintenance and Care of laboratory animal. CIGB.
Cuba.
3. Generation and obtention of Monoclonal Antibodies. Large-Scale
production. INCQS (Inst. National of Quality Control for Health).
Brazil. 1992
4. Iberoamerican course about Care and Use of Laboratory Animal.
Animal Models. Use in Biomedicine. CIGB. Sept. 1994
5. Lineaments and Directresses for Maintenance and Care of laboratory
animal. CIGB. Sept.-Nov 1994, Cuba.
6. "Care and Use of laboratory Animal. Scale of ascites tumoral
production. Bellaterra University. Barcelona. Spain. Septembre.1994.
7. Guidelines for maintenance and care of laboratory animal. CIGB.
Sept.-Nov 1995, Cuba.
8. Guidelines for maintenance and care of laboratory animal. CIGB.
Sept.-Nov 1996. Cuba.
9. Guidelines for maintenance and care of laboratory animal. Biomodels.
April 1997
10. Guidelines for maintenance and care of laboratory animal CIGB.
Sept.-Nov 1997. Cuba.
11. Updating regulations for auditors of quality control.1999
12. Coordinator and principal professor of the course about "Guidelines
for Use and Care of the laboratory animals. CIGB. 2000
13. Coordinator and principal professor of the course about "Guidelines
for Use and Care of the laboratory animals. CIGB. 2002
International events celebrates in Cuba
1. Recommendations for one system of tumoral ascites production
in mice employed for antibodies purification. Congress of Biotechnology
/ Havana 1989. Cartel. April 1989
2. Direct diagnostic of C. trachomatis in patient's samples mediated
for monoclonal antibodies. Cartel. April. 1989.
3. Utilization one primer generation hybrid in scale production
of tumoral Ascites again Mabs HBsAg. Cartel. Biotechnology / Havana
1990.
4. Ag. preparation. Control for diagnostic use practice of Mabs.
Cartel. April. 1992.
5. Large scale Monoclonal Antibody production in ascites using
Balb/c and Balb/c-derived cross-bred mice. Conference ICLAS meeting
in Centro Americana and Caribbean area. Conference. June1992
6. In vitro Production of Monoclonal Antibodies using a Semi automated
Hollow Fiber Bioreactor. Biotechnology / Havana 1992. Cartel.
7. Utilization of the ozone in drink water for laboratory animals.
International Symposium of ozone. March 1997.
8. "Employ line dog and rabbits in comparative characterization
pharmacokinetic / pharmacodinamic of trombolitics recombinant
Streptokinase SK MUT C-42. XII Meeting of Latin-American Association
of Animal Production (ALPA) Conventions Palace. 19-23 Nov. Cuba
2001
9. "Application of GMP in monogastrics species employed in
biomedical Science. Palace of Conventions. Conference 19-23 Nov.
2001 Cuba X National Meeting of Cuban Association for Animal Production
(ACPA)
10. "Employed of deferent's species animals in control and
security of Cuban recombinant hepatitis B vaccine. XII Meeting
of Latin-American Association for Animal Production (ALPA) Conventions
Palace 19-23 Nov. Cuba 2001
11. Determination in vivo of biological activity of Human Factor
Transfer. Alternative Technical International Symposium of interferon
and Cytokine. CIGB 2001
12. Evaluation of the recombinant Streptokinase as antigen for
determination of biological activity of the Human Transfer Factor.
International Symposium of interferon and Cytokine. CIGB. 2001
13. Security study of the Human Transfer obtained again no induced
cells, administrate by intramuscular source in SD rats. International
Symposium of interferon and Cytokine CIGB 2001
14. Quality Assurance in non clinical studies Stimulator Factor
of Colonies of Granulocyte human recombinant. International Symposium
of interferon and Cytokine CIGB 2001
15. Security, efficacy and effectively of the human recombinant
Erythropoietin. International Symposium of interferon and Cytokine.
CIGB 2001
16. Evaluations of security of recombinant IL-2 in SD rats. International
Symposium of interferon and Cytokine. CIGB 2001
17. Show studies of security and efficacy of the Stimulator Factor
of Colonies of Granulocyte, produced in CIGB. 2001
18. Cytokines pattern th 1 /th 2 in animal model of induced Arthritis.
International Symposium of interferon and Cytokine. CIGB 2001
INTERNACIONAL EVENTS CELEBRATES OUT CUBA.
1. Scale of reproduction of primer generation line bred OFBALB-F1,
obtained in CIGB Biotherium. III Congress of SECAL. Granada. Spain.
Nov.1994.
2. Scale of ascites tumoral production in Mabs. again lines Balb/c
and hybrids mice. III Congress of SECAL. Granada. Spain. Nov.
1994.
3. Use of laboratory Animal for control to cuban hepatitis B recombinant
vaccine. Employ barriers areas. II Course of Biomodels. Costa
Rica. 1997.
4. Influence of residual humidity in micro and macro-environment
in BALB/c mice. Costa Rica. 1997.
5. Immunologic characterization of HBsAg with component of one
combined DPTc-HB vaccine. Costa Rica. 1997.
6. "Obtention, use and care for laboratory animal in Gnotobiotic
conditions". II Course about Animal Models in Experimentation.
Costa Rica, University 1997.
7. Control in vivo of cuban hepatitis B recombinant vaccine and
bovine tick (GAVAC) in barriers zones. XVI Congress PANVET/98
Bolivia
8. Utilization laboratory animals in immunization systems. XVI
Congress PANVET/98 Bolivia.
9. GMP application of the monogastrics species employed biomedical
Science IV Congress of Society Spain for Science Laboratory Animal
(SECAL).. Zaragoza 12-14 Nov. Spain. 2001
10. Employ of different animals species in control and security
of cuban hepatitis B recombinant vaccine. IV Congress of Society
Spain for Science Laboratory Animal (SECAL). "Zaragoza 12-14
Nov. Spain 2001
11. "Employ dog, rabbits lines in comparative characterization
pharmacokinetic / pharmacodinamic of trombolitics recombinant
Streptokinase SK MUT C-42. IV Congress of Society Spain for Science
Laboratory Animal (SECAL). Zaragoza 12-14 Nov. Spain 2001
12. "Good Manufacturing Practices (GMP) applied to the Care
and Use of Laboratory Animals employed in biological assays and
quality control. Hepatitis B vaccine and Human Factor Transfer.
VIII Symposium FELASA. Aachen, Germany. 2002
National events.
1. Recommendations for establishment one System for high volumes
of ascites tumoral production again monoclonal antibodies. IV
Seminary scientific of the National Centre of Agriculture Sanity.
October 1987.
2. Systems of maintenance for animals in isolators. Second Meeting
of Laboratory Animals. Cartel. Marzo.1993
3. Study of deferent adjutants for obtention of major's volumes
tumoral ascites again Mabs. Cartel. 1992
4. Scale of reproduction one Biomodel for obtention tumoral ascites.
Conference. Nov. 1993
5. Standard Operation Procedure for Maintenance of mice in CIGB
Biotherium CIGB. Cartel. 1993
6. Maintenance of animals in protected zones. Nov. 1993.
7. Potency test of Hepatitis B recombinant vaccine. Nov. 1993
Participation in others activities of scientific
exchange
- Congress of Biotechnology / Havana 1989
- III seminary international about Interferon. April 1989.
- II Latin-American Congress Biotechnology. Taller of Gnotobiology.
Experimentation Animals for health. August1990
- ICLAS meeting in Centro American and Caribbean area. Nov. 1990
- Congress of Biotechnology / Havana 1992.
- Symposium FIOCRUZ-Inst. Pasteur. Dic. 1992
- International Symposium for advanced systems of the medicaments
administration. April 1993.
- II Meeting of ICLAS. Nov. 1993
- Congress of Biotechnology / Havana 1994 (Organizer Committee)
- Congress of Biotechnology / Havana Nov. 95. (Organized Committee)
- Confection of Sanitary Register for Hepatitis B recombinant
Vaccine (Heberbiovac HB). CIGB 1997
- Congress of Biotechnology/ Havana. December 1997 (Organized
Committee)
- 2nd International Symposium of Applications of the Ozone.1997
Center for Investigations of Ozone. March 1997
- Taller of biological assays. September 1997
- XVI congress Panamerican of Veterinarians Science. August 1998
- Congress of Biotechnology / Havana. November 99
- Congress of Biotechnology / Havana 99. "Production of tumoral
ascites again hybrid mice of primer generation. Application of
Good Manufacturing Practice.1999
- XII Congress of ICLAS and FELASA conference. Mallorca, Spain.
May 1999.
- Latin-American Congress of New Word Primatology. Bogotá
2001
Society and Commission Scientific members.
- Society of Interferon and Biotechnology. 1986
- Society Spain for laboratory Animal Science. SECAL. 1992
- Coordinator of Commission Cuba. Association Centro American,
Caribbean and Mexican of Laboratory animal science (ACCMAL). 1992.
PUBLICATIONS:
1. Employ of primer generation hybrids mice OFBALB-F1 in fluid
ascites production again Mabs. Vol. 8. Biotecnología Aplicada,
1991.
2. In vitro Production of Monoclonal antibodies using Semi automated
Hollow Fiber Bioreactor. Vol. 10 Biotecnología Aplicada
1993.
3. Animals Immunoresponse to the Cuban recombinant yeas-derived
anti Hepatitis B viral Surface Antigen (rec. HBsAg.) Vaccine.
Vol.10 Biotec. Aplicada, 1993
4. Large Scale Monoclonal Antibody production in ascites using
BALB/c and BALB/c-derived cross- bred mice. Vol.10 Biotech. Aplicada.
1993
5. Murine monoclonal antibodies specific for the HBsAg "a".
Biotech. Aplicada, Vol.12 No. 2, 1995.
6. Study of the environmental influence in response of antibody
for Hepatitis B recombinant vaccine (Heberbiovac HB). Technical
inform. February 1996.
7. Application of treatment water with ozone for laboratory animal
breeding free of germ pathogen.1998.
8. Methodology for control environmental in Gnotobiotic animals
areas. 1999.
9. Monoclonal antibodies production for method of ascites in endogamyc
strain BALB/c and hybrid mice OF-1. 1999
10. ALFEBEA a network to harmonize laboratory animal science education
and training between Europe and America 1999.
11. Immunologic comportment of the HBsAg with to component one
combined DPTc-HB vaccine. 2000.
Received Premiums:
. Obtention and production of antigen for control of Clamidia
trachomatis detection for diagnostic use Mabs and direct diagnostic
in patients' samples. Scientific Institutional Premium 1987-1988.
. Production of tumoral ascites again monoclonal antibody CB-IFN
alfa 2b. Sanitary adequation and initialization installations
for animals according to Guide for Use and Care for laboratory
animal (NRC, 1985). Scientific Premium Cuba Academic Science in
quinquennium 1986-1990.
. Production of monoclonal antibody in bioreactors. Institutional
Premium. 1990 1991.
. Establishment of scale in process of production for obtention
human Interferon alfa 2b for recombinant source. Scientific National
Premium of quinquennium. Cuba Academic Science 1986-1990.
. Establishment of one documentation System for compliments of
Good Manufacturing Practice and Laboratory Practice in CIGB and
their automatic control. Scientific Institutional Premium 1993.
. Scale of ascites tumoral production again Mabs CB/HEP.1 and
Transference of technology for ascites tumoral production at CENPALAB.
Scientific Institutional Premium, National Premium of Academic
Science of Cuba (ACC). 1994.
. Concurs of Total Quality. Firth Mention. CIGB. Cuba. 1994.
. Hybridoma productor of high levels of specific antibody HBsAg,
for purification of the vacunal antigen. Scientific Institutional
Premium 1994.
. System of production for high scale of tumoral ascites in protected
zones. Development technological transfer. Scientific Institutional
Premium, CIGB 1994.
. Establishment conditions of maintenance and care of animals
according to GMP. Scientific Institutional Premium 1994-1995.
. Better economic result and Special Premium of Science Technology
and Environment Minister 1995-1997. (CITMA). 1997.
. Establishment and introduction of one environmental program
for Gnotobiotic animal's areas employed in quality control of
biopharmaceuticals products. Scientific Institutional Premium.1998
. Especial Premium CITMA 1998 for the scientific result than more
economic impact in this year "Development and introduction
of new methods fermentation, immunoafinity and ionic exchange
and increase significative the capability of HBsAg production
for elaboration of the Cuban vaccine HEBERBIOVAC (HB) in 1996
and 1997.
Scientific-Technical Associations.
. SECAL 1992 Member. Spain.
. ACCMAL 1993 National Coordinator. Costa Rica.
. Pan-American Association of Veterinarian Science.1998. Member.
Cuba
. Cuban Society of laboratory animal.1999. Member. Cuba
. Society Brazilian of Animal Welfare.1999. Member. Brazil.
Scientific distinctions.
. Certificate: For your participation in: "Establishment
an production process of recombinant human Interferon alfa 2b":
Scientific Premium of ACC. 1986-1990. CIGB-ACC.
. Certificate: Institutional Premium. "Production of Mabs
in Bioreactors".1990 CIGB.
. Scientific Premium of the ACC. "Scale commercial production
and demonstration of the innocuously and effectively the one cuban
recombinant hepatitis B vaccine.1992
. Certificate: Scientific Premium of the ACC. "Large scale
of ascites tumoral production". 1993
. Certificate: Institutional Premium. "Establishment of integral
documentation system for the compliment of GMP and GLP in CIGB
and their automatic control".1993.CIGB
. Certificate: Institutional Premium. "Transference ascites
tumoral production again monoclonal antibodies". 1994.CIGB
. Certificate: Institutional Premium. "Hybridoma productor
high levels of specific antibody (HBsAg) use in vacunal antigen
purification".1994.CIGB
. Certificate: Firth mention in concurs of total quality.1994.CIGB
. Diploma: Relevant National Premium. "System of large-scale
production of ascites tumoral in protected areas. Development
technological transference". 1994. IX Forum of Science and
technical.
. Certificate: Institutional Premium and National premium Relevant.
"Scale industrial Production of the CB-HEP1 monoclonal antibody
for the immunopurification of recombinant antigen of hepatitis
B virus employed as vacunal prepared".1995.CIGB
. Certificate: Institutional Premium. "Introduction and establishment
the one environmental monitoring program for Gnotobiotics laboratory
animals areas employed in quality control of biopharmaceuticals
products". 1998 CIGB
. Recognized for magisterial conference and elevated participation.
XVI Panamerican Congress Veterinaria Science. Bolivia, 1998
. Institutional Premium. "Establishment and introduction
of counter procedures in animal experimentation". Institutional
Premium 2000
. Institutional Premium " Establishment and application of
GMP at the laboratory animals" 2000
. Institutional Premium "Demonstration quality of the Heberbiovac
HB vaccine front other competency vaccine ". 2000
. Institutional Premium "Cuban combined vaccine Diphtheria,
Pertussis, Tetanus and Hepatitis B (DPT-HB): Formulation study
and evaluation their prolonged stability". 2000
. Institutional Premium "Ingress of the CIGB in Global Alliance
Vaccine and Immunization (GAVI) as result the satisfactory evaluation
of defended document, in front one Consulter of WHO. 2000
. Scientific Premium of the ACC. Definition of one hepatitis C
virus vacunal again results pre-clinical assays. 2000.
. Institutional Premium "Obtention of one Biomodel for immunogenicity
determination of the H. influenzae vacunal prepared. 2001.
. Prominent Thesis of Doctor in Science at National level. 2000
. Institutional Premium. "Establishment of one Technology
for obtention plasmidic DNA for therapeutic use and human vacunal".
2001
. Institutional Premium "Establishment of one process for
obtention of G-CSF. Security and efficacy of evaluation. 2001
. Institutional Premium "Establishment bactericide assays
for vacunal prepared evaluation again H. influenzae type b"
2001